Literature DB >> 26607490

Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer.

Deena M A Gendoo1, Natchar Ratanasirigulchai2, Markus S Schröder3, Laia Paré4, Joel S Parker5, Aleix Prat6, Benjamin Haibe-Kains1.   

Abstract

UNLABELLED: Breast cancer is one of the most frequent cancers among women. Extensive studies into the molecular heterogeneity of breast cancer have produced a plethora of molecular subtype classification and prognosis prediction algorithms, as well as numerous gene expression signatures. However, reimplementation of these algorithms is a tedious but important task to enable comparison of existing signatures and classification models between each other and with new models. Here, we present the genefu R/Bioconductor package, a multi-tiered compendium of bioinformatics algorithms and gene signatures for molecular subtyping and prognostication in breast cancer.
AVAILABILITY AND IMPLEMENTATION: The genefu package is available from Bioconductor. http://www.bioconductor.org/packages/devel/bioc/html/genefu.html Source code is also available on Github https://github.com/bhklab/genefu CONTACT: bhaibeka@uhnresearch.ca SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2015        PMID: 26607490      PMCID: PMC6410906          DOI: 10.1093/bioinformatics/btv693

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  122 in total

1.  Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance).

Authors:  Mark Jesus M Magbanua; Hope S Rugo; Denise M Wolf; Louai Hauranieh; Ritu Roy; Praveen Pendyala; Eduardo V Sosa; Janet H Scott; Jin Sun Lee; Brandelyn Pitcher; Terry Hyslop; William T Barry; Steven J Isakoff; Maura Dickler; Laura Van't Veer; John W Park
Journal:  Clin Cancer Res       Date:  2018-01-08       Impact factor: 12.531

2.  Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer.

Authors:  Edoardo Isnaldi; Domenico Ferraioli; Lorenzo Ferrando; Alberto Ballestrero; Gabriele Zoppoli; Sylvain Brohée; Fabio Ferrando; Piero Fregatti; Davide Bedognetti
Journal:  Breast Cancer Res Treat       Date:  2019-06-20       Impact factor: 4.872

3.  Standardized versus research-based PAM50 intrinsic subtyping of breast cancer.

Authors:  A Prat; J S Parker
Journal:  Clin Transl Oncol       Date:  2019-08-21       Impact factor: 3.405

4.  Normal Breast-Derived Epithelial Cells with Luminal and Intrinsic Subtype-Enriched Gene Expression Document Interindividual Differences in Their Differentiation Cascade.

Authors:  Brijesh Kumar; Mayuri Prasad; Poornima Bhat-Nakshatri; Manjushree Anjanappa; Maitri Kalra; Natascia Marino; Anna Maria Storniolo; Xi Rao; Sheng Liu; Jun Wan; Yunlong Liu; Harikrishna Nakshatri
Journal:  Cancer Res       Date:  2018-07-11       Impact factor: 12.701

5.  A Longitudinal Study of the Association between Mammographic Density and Gene Expression in Normal Breast Tissue.

Authors:  Helga Bergholtz; Tonje Gulbrandsen Lien; Giske Ursin; Marit Muri Holmen; Åslaug Helland; Therese Sørlie; Vilde Drageset Haakensen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-01-06       Impact factor: 2.673

6.  Low cleaved caspase-7 levels indicate unfavourable outcome across all breast cancers.

Authors:  Andreas U Lindner; Federico Lucantoni; Damir Varešlija; Alexa Resler; Brona M Murphy; William M Gallagher; Arnold D K Hill; Leonie S Young; Jochen H M Prehn
Journal:  J Mol Med (Berl)       Date:  2018-08-01       Impact factor: 4.599

7.  SIGN: similarity identification in gene expression.

Authors:  Seyed Ali Madani Tonekaboni; Venkata Satya Kumar Manem; Nehme El-Hachem; Benjamin Haibe-Kains
Journal:  Bioinformatics       Date:  2019-11-01       Impact factor: 6.937

8.  Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer.

Authors:  Tstutomu Kawaguchi; Li Yan; Qianya Qi; Xuan Peng; Stephen B Edge; Jessica Young; Song Yao; Song Liu; Eigo Otsuji; Kazuaki Takabe
Journal:  Ann Surg Oncol       Date:  2018-10-11       Impact factor: 5.344

9.  Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian Versus Western Populations.

Authors:  Ching-Hsuan Chen; Yen-Shen Lu; Ann-Lii Cheng; Chiun-Sheng Huang; Wen-Hung Kuo; Ming-Yang Wang; Ming Chao; I-Chun Chen; Chun-Wei Kuo; Tzu-Pin Lu; Ching-Hung Lin
Journal:  Oncologist       Date:  2019-08-01

10.  Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide.

Authors:  Su-Hyeong Kim; Catherine H Kaschula; Nolan Priedigkeit; Adrian V Lee; Shivendra V Singh
Journal:  J Biol Chem       Date:  2016-04-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.